John Gordan, MD, PhD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address1700 4th St, #308A
San Francisco CA 94158
Phone415-353-9888
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard College, Boston, MAAB6/2001Biochemistry
    University of Pennsylvania, Philadelphia, PAPhD12/2007Cancer Biology
    University of Pennsylvania, Philadelphia, PAMD5/2009

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma. Drugs. 2023 Aug; 83(12):1091-1109. Gordan JD, Keenan BP, Lim HC, Yarchoan M, Kelley RK. PMID: 37402062.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma. bioRxiv. 2023 Jun 28. Lauer SM, Omar MH, Golkowski MG, Kenerson HL, Pascual BC, Forbush K, Smith FD, Gordan J, Ong SE, Yeung RS, Scott JD. PMID: 37425703; PMCID: PMC10327129.
      View in: PubMed   Mentions:
    3. Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data. NPJ Precis Oncol. 2023 Mar 23; 7(1):29. Zack T, Losert KP, Maisel SM, Wild J, Yaqubie A, Herman M, Knox JJ, Mayer RJ, Venook AP, Butte A, O'Neill AF, Abou-Alfa GK, Gordan JD. PMID: 36959495; PMCID: PMC10034241.
      View in: PubMed   Mentions: 1  
    4. Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms. Elife. 2023 01 24; 12. Chan GKL, Maisel S, Hwang YC, Pascual BC, Wolber RRB, Vu P, Patra KC, Bouhaddou M, Kenerson HL, Lim HC, Long D, Yeung RS, Sethupathy P, Swaney DL, Krogan NJ, Turnham RE, Riehle KJ, Scott JD, Bardeesy N, Gordan JD. PMID: 36692000; PMCID: PMC9925115.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma. Cancer Discov. 2022 05 02; 12(5):1378-1395. Wu Q, Zhen Y, Shi L, Vu P, Greninger P, Adil R, Merritt J, Egan R, Wu MJ, Yin X, Ferrone CR, Deshpande V, Baiev I, Pinto CJ, McLoughlin DE, Walmsley CS, Stone JR, Gordan JD, Zhu AX, Juric D, Goyal L, Benes CH, Bardeesy N. PMID: 35420673; PMCID: PMC9064956.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    6. Methods to assess small molecule allosteric modulators of the STRAD pseudokinase. Methods Enzymol. 2022; 667:427-453. Qing T, Liu J, Liu F, Mitchell DC, Beresis RT, Gordan JD. PMID: 35525550.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    7. A framework for fibrolamellar carcinoma research and clinical trials. Nat Rev Gastroenterol Hepatol. 2022 05; 19(5):328-342. Dinh TA, Utria AF, Barry KC, Ma R, Abou-Alfa GK, Gordan JD, Jaffee EM, Scott JD, Zucman-Rossi J, O'Neill AF, Furth ME, Sethupathy P. PMID: 35190728; PMCID: PMC9516439.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    8. Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1. Oncogene. 2022 03; 41(11):1536-1549. Melnyk JE, Steri V, Nguyen HG, Hwang YC, Gordan JD, Hann B, Feng FY, Shokat KM. PMID: 35087237; PMCID: PMC8913362.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    9. A protein interaction landscape of breast cancer. Science. 2021 Oct; 374(6563):eabf3066. Kim M, Park J, Bouhaddou M, Kim K, Rojc A, Modak M, Soucheray M, McGregor MJ, O'Leary P, Wolf D, Stevenson E, Foo TK, Mitchell D, Herrington KA, Muñoz DP, Tutuncuoglu B, Chen KH, Zheng F, Kreisberg JF, Diolaiti ME, Gordan JD, Coppé JP, Swaney DL, Xia B, van 't Veer L, Ashworth A, Ideker T, Krogan NJ. PMID: 34591612; PMCID: PMC9040556.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    10. Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling. Liver Cancer. 2021 Nov; 10(6):561-571. Kelley RK, Joseph NM, Nimeiri HS, Hwang J, Kulik LM, Ngo Z, Behr SC, Onodera C, Zhang K, Bocobo AG, Benson AB, Venook AP, Gordan JD. PMID: 34950179; PMCID: PMC8647100.
      View in: PubMed   Mentions: 5  
    11. STRAD-binding agents and uses thereof. 2021. Gordan JD, Mitchell DC, Beresis RT, Adler M.
    12. Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma. PLoS Comput Biol. 2021 02; 17(2):e1008699. Lim HC, Gordan JD. PMID: 33561166; PMCID: PMC7909678.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    13. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline. J Clin Oncol. 2020 12 20; 38(36):4317-4345. Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Gade TP, Goff L, Gupta S, Guy J, Harris WP, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Knox JJ, Kortmansky J, Leaf A, Remak WM, Shroff RT, Sohal DPS, Taddei TH, Venepalli NK, Wilson A, Zhu AX, Rose MG. PMID: 33197225.
      View in: PubMed   Mentions: 214     Fields:    Translation:HumansCTClinical Trials
    14. Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells. Cancer Cell. 2020 07 13; 38(1):129-143.e7. Coles GL, Cristea S, Webber JT, Levin RS, Moss SM, He A, Sangodkar J, Hwang YC, Arand J, Drainas AP, Mooney NA, Demeter J, Spradlin JN, Mauch B, Le V, Shue YT, Ko JH, Lee MC, Kong C, Nomura DK, Ohlmeyer M, Swaney DL, Krogan NJ, Jackson PK, Narla G, Gordan JD, Shokat KM, Sage J. PMID: 32531271; PMCID: PMC7363571.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    15. A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma. Oncologist. 2020 11; 25(11):925-e1603. El Dika I, Mayer RJ, Venook AP, Capanu M, LaQuaglia MP, Kobos R, O'Neill AF, Chou JF, Ly M, Ang C, O'Reilly EM, Gordan JD, Abou-Alfa GK. PMID: 32400000; PMCID: PMC7648371.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    16. Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma. Clin Liver Dis (Hoboken). 2020 Feb; 15(2):53-58. Huppert LA, Gordan JD, Kelley RK. PMID: 32226615; PMCID: PMC7098670.
      View in: PubMed   Mentions: 16  
    17. Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma. Oncologist. 2020 12; 25(12):e1837-e1845. Abou-Alfa GK, Mayer R, Venook AP, O'Neill AF, Beg MS, LaQuaglia M, Kingham PT, Kobos R, Basturk O, Brennan C, Yopp A, Harding JJ, Leong S, Crown J, Hoti E, Leonard G, Ly M, Bradley M, Valentino E, Markowitz D, Zukiwski A, Ren K, Gordan JD. PMID: 32154962; PMCID: PMC8186410.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    18. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. Elife. 2019 09 03; 8. McMahon M, Contreras A, Holm M, Uechi T, Forester CM, Pang X, Jackson C, Calvert ME, Chen B, Quigley DA, Luk JM, Kelley RK, Gordan JD, Gill RM, Blanchard SC, Ruggero D. PMID: 31478838; PMCID: PMC6776443.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    19. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis. J Hepatol. 2019 10; 71(4):742-752. Wang J, Wang H, Peters M, Ding N, Ribback S, Utpatel K, Cigliano A, Dombrowski F, Xu M, Chen X, Song X, Che L, Evert M, Cossu A, Gordan J, Zeng Y, Chen X, Calvisi DF. PMID: 31195063; PMCID: PMC6773530.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    20. Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series. Cancer. 2019 09 15; 125(18):3234-3241. Kambhampati S, Bauer KE, Bracci PM, Keenan BP, Behr SC, Gordan JD, Kelley RK. PMID: 31154669.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    21. KRASG12C inhibition produces a driver-limited state revealing collateral dependencies. Sci Signal. 2019 05 28; 12(583). Lou K, Steri V, Ge AY, Hwang YC, Yogodzinski CH, Shkedi AR, Choi ALM, Mitchell DC, Swaney DL, Hann B, Gordan JD, Shokat KM, Gilbert LA. PMID: 31138768; PMCID: PMC6871662.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    22. MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment. Cell Death Dis. 2019 02 11; 10(2):120. Wang P, Song X, Utpatel K, Shang R, Yang YM, Xu M, Zhang J, Che L, Gordan J, Cigliano A, Seki E, Evert M, Calvisi DF, Hu X, Chen X. PMID: 30741922; PMCID: PMC6370758.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    23. Road map for fibrolamellar carcinoma: progress and goals of a diversified approach. J Hepatocell Carcinoma. 2019; 6:41-48. Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK. PMID: 30951568; PMCID: PMC6362920.
      View in: PubMed   Mentions: 2  
    24. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nat Med. 2019 02; 25(2):301-311. Xu Y, Poggio M, Jin HY, Shi Z, Forester CM, Wang Y, Stumpf CR, Xue L, Devericks E, So L, Nguyen HG, Griselin A, Gordan JD, Umetsu SE, Reich SH, Worland ST, Asthana S, Barna M, Webster KR, Cunningham JT, Ruggero D. PMID: 30643286; PMCID: PMC6613562.
      View in: PubMed   Mentions: 102     Fields:    Translation:AnimalsCells
    25. Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation. Oncogene. 2019 03; 38(11):1936-1950. Frazier NM, Brand T, Gordan JD, Grandis J, Jura N. PMID: 30390071; PMCID: PMC6417953.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    26. Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma. Clin Cancer Res. 2019 01 01; 25(1):403-413. Song X, Liu X, Wang H, Wang J, Qiao Y, Cigliano A, Utpatel K, Ribback S, Pilo MG, Serra M, Gordan JD, Che L, Zhang S, Cossu A, Porcu A, Pascale RM, Dombrowski F, Hu H, Calvisi DF, Evert M, Chen X. PMID: 30084835; PMCID: PMC6423983.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    27. Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer. Nat Chem Biol. 2018 08; 14(8):768-777. Donnella HJ, Webber JT, Levin RS, Camarda R, Momcilovic O, Bayani N, Shah KN, Korkola JE, Shokat KM, Goga A, Gordan JD, Bandyopadhyay S. PMID: 29942081; PMCID: PMC6051919.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    28. Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion. Oncologist. 2018 09; 23(9):998-1003. Lim HC, Montesion M, Botton T, Collisson EA, Umetsu SE, Behr SC, Gordan JD, Stephens PJ, Kelley RK. PMID: 29622700; PMCID: PMC6192605.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. Oncogene. 2018 06; 37(24):3229-3242. Wang J, Dong M, Xu Z, Song X, Zhang S, Qiao Y, Che L, Gordan J, Hu K, Liu Y, Calvisi DF, Chen X. PMID: 29545603; PMCID: PMC6002343.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCells
    30. Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model. Cell Death Dis. 2018 01 18; 9(2):31. Dong M, Liu X, Evert K, Utpatel K, Peters M, Zhang S, Xu Z, Che L, Cigliano A, Ribback S, Dombrowski F, Cossu A, Gordan J, Calvisi DF, Evert M, Liu Y, Chen X. PMID: 29348467; PMCID: PMC5833851.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    31. Sampling strategies to capture single-cell heterogeneity. Nat Methods. 2017 Oct; 14(10):967-970. Rajaram S, Heinrich LE, Gordan JD, Avva J, Bonness KM, Witkiewicz AK, Malter JS, Atreya CE, Warren RS, Wu LF, Altschuler SJ. PMID: 28869755; PMCID: PMC5658002.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    32. Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice. J Hepatol. 2017 12; 67(6):1194-1203. Zhang S, Song X, Cao D, Xu Z, Fan B, Che L, Hu J, Chen B, Dong M, Pilo MG, Cigliano A, Evert K, Ribback S, Dombrowski F, Pascale RM, Cossu A, Vidili G, Porcu A, Simile MM, Pes GM, Giannelli G, Gordan J, Wei L, Evert M, Cong W, Calvisi DF, Chen X. PMID: 28733220; PMCID: PMC5696057.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    33. An Optimized Chromatographic Strategy for Multiplexing In Parallel Reaction Monitoring Mass Spectrometry: Insights from Quantitation of Activated Kinases. Mol Cell Proteomics. 2017 02; 16(2):265-277. Urisman A, Levin RS, Gordan JD, Webber JT, Hernandez H, Ishihama Y, Shokat KM, Burlingame AL. PMID: 27940637; PMCID: PMC5294213.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    34. Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib. Mol Cancer Ther. 2016 07; 15(7):1472-84. Miller RE, Brough R, Bajrami I, Williamson CT, McDade S, Campbell J, Kigozi A, Rafiq R, Pemberton H, Natrajan R, Joel J, Astley H, Mahoney C, Moore JD, Torrance C, Gordan JD, Webber JT, Levin RS, Shokat KM, Bandyopadhyay S, Lord CJ, Ashworth A. PMID: 27364904.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    35. Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma. Cancer Discov. 2016 07; 6(7):727-39. Saha SK, Gordan JD, Kleinstiver BP, Vu P, Najem MS, Yeo JC, Shi L, Kato Y, Levin RS, Webber JT, Damon LJ, Egan RK, Greninger P, McDermott U, Garnett MJ, Jenkins RL, Rieger-Christ KM, Sullivan TB, Hezel AF, Liss AS, Mizukami Y, Goyal L, Ferrone CR, Zhu AX, Joung JK, Shokat KM, Benes CH, Bardeesy N. PMID: 27231123; PMCID: PMC5458737.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansAnimalsCells
    36. Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish. PLoS Genet. 2015 Jul; 11(7):e1005305. Evason KJ, Francisco MT, Juric V, Balakrishnan S, Lopez Pazmino Mdel P, Gordan JD, Kakar S, Spitsbergen J, Goga A, Stainier DY. PMID: 26134322; PMCID: PMC4489858.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    37. Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map. Cancer Discov. 2015 02; 5(2):154-67. Martins MM, Zhou AY, Corella A, Horiuchi D, Yau C, Rakhshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji AF, Schreiber SL, Krogan NJ, Shokat KM, McCormick F, Goga A, Bandyopadhyay S. PMID: 25501949; PMCID: PMC4407699.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    38. Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors. Cell Rep. 2014 Aug 21; 8(4):1037-48. Sos ML, Levin RS, Gordan JD, Oses-Prieto JA, Webber JT, Salt M, Hann B, Burlingame AL, McCormick F, Bandyopadhyay S, Shokat KM. PMID: 25127139; PMCID: PMC4294625.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    39. Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets. Cancer Res. 2012 Jan 01; 72(1):112-21. Dondeti VR, Wubbenhorst B, Lal P, Gordan JD, D'Andrea K, Attiyeh EF, Simon MC, Nathanson KL. PMID: 22094876; PMCID: PMC3251639.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    40. "And what other medications are you taking?". J Clin Oncol. 2011 Apr 10; 29(11):e288-91. Gordan JD, Chay WY, Kelley RK, Ko AH, Choo SP, Venook AP. PMID: 21245436.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    41. HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc Natl Acad Sci U S A. 2009 Aug 25; 106(34):14391-6. Bertout JA, Majmundar AJ, Gordan JD, Lam JC, Ditsworth D, Keith B, Brown EJ, Nathanson KL, Simon MC. PMID: 19706526; PMCID: PMC2726037.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    42. Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene. 2009 Jul 09; 28(27):2513-23. Wright TM, Brannon AR, Gordan JD, Mikels AJ, Mitchell C, Chen S, Espinosa I, van de Rijn M, Pruthi R, Wallen E, Edwards L, Nusse R, Rathmell WK. PMID: 19448672; PMCID: PMC2771692.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    43. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell. 2008 Dec 09; 14(6):435-46. Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL. PMID: 19061835; PMCID: PMC2621440.
      View in: PubMed   Mentions: 275     Fields:    Translation:HumansCells
    44. Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism. J Biol Chem. 2008 Jun 13; 283(24):16309-19. Young RM, Wang SJ, Gordan JD, Ji X, Liebhaber SA, Simon MC. PMID: 18430730; PMCID: PMC2423241.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    45. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell. 2007 Aug; 12(2):108-13. Gordan JD, Thompson CB, Simon MC. PMID: 17692803; PMCID: PMC3215289.
      View in: PubMed   Mentions: 383     Fields:    Translation:HumansCells
    46. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev. 2007 May 01; 21(9):1037-49. Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, Simon MC, Thompson CB. PMID: 17437992; PMCID: PMC1855230.
      View in: PubMed   Mentions: 192     Fields:    Translation:AnimalsCells
    47. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell. 2007 Apr; 11(4):335-47. Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC. PMID: 17418410; PMCID: PMC3145406.
      View in: PubMed   Mentions: 410     Fields:    Translation:HumansAnimalsCells
    48. Hypoxia-inducible factors: central regulators of the tumor phenotype. Curr Opin Genet Dev. 2007 Feb; 17(1):71-7. Gordan JD, Simon MC. PMID: 17208433; PMCID: PMC3215290.
      View in: PubMed   Mentions: 212     Fields:    Translation:Humans
    49. Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J Biol Chem. 2006 Oct 06; 281(40):30036-45. Zhang F, Hamanaka RB, Bobrovnikova-Marjon E, Gordan JD, Dai MS, Lu H, Simon MC, Diehl JA. PMID: 16893887.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    50. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 2006 Mar 01; 20(5):557-70. Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ, Labosky PA, Simon MC, Keith B. PMID: 16510872; PMCID: PMC1410808.
      View in: PubMed   Mentions: 367     Fields:    Translation:AnimalsCells
    51. ADAP-SLP-76 binding differentially regulates supramolecular activation cluster (SMAC) formation relative to T cell-APC conjugation. J Exp Med. 2004 Oct 18; 200(8):1063-74. Wang H, McCann FE, Gordan JD, Wu X, Raab M, Malik TH, Davis DM, Rudd CE. PMID: 15477347; PMCID: PMC2211848.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCells
    52. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol. 2004 Oct; 24(19):8477-86. Cullinan SB, Gordan JD, Jin J, Harper JW, Diehl JA. PMID: 15367669; PMCID: PMC516753.
      View in: PubMed   Mentions: 428     Fields:    Translation:AnimalsCells
    53. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer. 1999 Nov 12; 83(4):456-64. Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Gure AO, Jäger D, Jäger E, Knuth A, Chen YT, Old LJ. PMID: 10508479.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    54. Isoforms of the human PDZ-73 protein exhibit differential tissue expression. Biochim Biophys Acta. 1999 Apr 14; 1445(1):39-52. Scanlan MJ, Williamson B, Jungbluth A, Stockert E, Arden KC, Viars CS, Gure AO, Gordan JD, Chen YT, Old LJ. PMID: 10209257.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    55. Aspects of GnRH neurobiology conserved across vertebrate forms. Gen Comp Endocrinol. 1998 Dec; 112(3):276-82. Dellovade T, Schwanzel-Fukuda M, Gordan J, Pfaff D. PMID: 9843633.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    56. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer. 1998 May 29; 76(5):652-8. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Türeci O, Sahin U, Pfreundschuh M, Old LJ. PMID: 9610721.
      View in: PubMed   Mentions: 79     Fields:    Translation:Humans
    57. Mathematical exploration of pulsatility in cultured gonadotropin-releasing hormone neurons. Neuroendocrinology. 1998 Jan; 67(1):2-17. Gordan JD, Attardi BJ, Pfaff DW. PMID: 9485164.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    58. Reproductive functions illustrating direct and indirect effects of genes on behavior. Horm Behav. 1996 Dec; 30(4):487-94. Ogawa S, Gordan JD, Taylor J, Lubahn D, Korach K, Pfaff DW. PMID: 9047273.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    59. Initial preparation of the periodontally advanced dentition. J Calif Dent Assoc. 1989 Sep; 17(9):25-8. Yang LR, Gordan J. PMID: 2484068.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    John's Networks
    Concepts (343)
    Derived automatically from this person's publications.
    _
    Co-Authors (47)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _